Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Depression
Interventions: Omega-3 Fatty Acids; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non-alcoholic Fatty Liver Disease, Fatty Liver
Interventions: Omega-3-acid ethyl esters, Placebo; Drug
Lead sponsor: Boston University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain
Interventions: Tart Cherry, Omega 3 FA (Fish Oil); Drug
Lead sponsor: Philip Chang; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Torrance, California

Conditions: Stress
Interventions: Chaga Mushroom, Algae Extract, Black Cumin Seed Oil, Black Cumin Seed Oil + Astaxanthin, Black Cumin Seed Oil + Omega 3, Placebo; Dietary Supplement
Lead sponsor: 3 Waves Wellness; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Plymouth, Massachusetts

Conditions: Non-verbal Learning Disorder, Autism Spectrum Disorder, Autism
Interventions: Open-label Treatment with Omega-3 Fatty Acids + Inositol, Open-label Treatment with N-acetylcysteine; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 5 Years to 17 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prostate Cancer
Interventions: Vitamin D, Omega-3, Turmeric; Dietary Supplement
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: Male only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Prematurity, Intestine Perforation, Necrotizing Enterocolitis (NEC), Short Bowel Syndrome (SBS)
Interventions: Microlipid with fish oil, Microlipid; Dietary Supplement
Lead sponsor: Wake Forest University; Other
Eligibility: 1 Day to 2 Months
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Bipolar Disorder
Interventions: Ethyl Eicosapentaenoic Acid; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure With Normal Ejection Fraction, Obesity
Interventions: Increasing daily unsaturated fatty acid consumption; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Depression
Interventions: EPA-rich fish oil supplement, DHA-rich fish oil supplement, placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Anxiety Disorders and Symptoms, Fibromyalgia, Arthritis, Chronic Pain, Hypertension,Essential
Interventions: IV Vitamin Infused Therapy Treatment, Herbal medicine; Dietary Supplement · Drug
Lead sponsor: Faith A. Richardson; Other
Eligibility: 21 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Dover, Delaware

Conditions: Parenteral Nutrition Associated Cholestasis
Interventions: Omegaven; Drug
Lead sponsor: Arthur J De Lorimier; Other
Eligibility: Up to 1 Year
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Major Depression, Cancer, Diabetes, Cardiovascular Diseases
Interventions: Desvenlafaxine, Omega 3 Fatty acids, Placebo (for Omega 3 fatty acid supplement); Drug · Dietary Supplement
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Heart Health Markers, Cardiovascular Diseases, Omega 3 Fatty Acids
Interventions: Omega-3 Fatty Acids and Safflower Oil Placebo, Safflower Oil Placebo and Omega-3 Fatty Acids; Dietary Supplement
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 64 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Tucson, Arizona • Washington D.C., District of Columbia

Conditions: Cholestasis
Interventions: Omegaven; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 2 Weeks to 18 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypercholesterolaemia
Interventions: alirocumab SAR236553 (REGN727), statins, ezetimibe, cholestyramine, fenofibrate, omega-3 fatty acids, nicotinic acid; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 8 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: St Louis, Missouri • Charlotte, North Carolina • Cincinnati, Ohio

Conditions: Sellar/Parasellar Tumor, Smell Dysfunction
Interventions: Omega-3; Dietary Supplement
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Stanford, California • Atlanta, Georgia

Conditions: Colorectal Adenomatous Polyps
Interventions: Eicosapentanoic acid and docosahexanoic acid, Oleic Acid; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 40 Years to 79 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Systemic Lupus Erythematosus
Interventions: Omega-3, flow-mediated dilation of the brachial artery, corn starch; Drug · Device · Other
Lead sponsor: Michelle Petri M.D.,MPH; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Hypertension
Interventions: Vitamin D-3 (cholecalciferol), 2000 IU, Omega-3 fatty acids (fish oil), Vitamin D placebo, Fish oil placebo; Dietary Supplement · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years to 99 Years
Enrollment: 25,875 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Deficit Disorder
Interventions: DHA Omega-3, Placebo; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 5 Years to 15 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years to 65 Years
Enrollment: 458 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Tobacco Use in Childbirth, Smoking Cessation, Pregnancy Related
Interventions: Fish oil, Placebos; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Omega-3 Fatty Acids, Lipid Peroxidation
Interventions: Omega-3 fish oil provided by salmon; Dietary Supplement
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 40 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Search by objective public record fields.

Omega-3 for Peri- and Postmenopausal Depression

Study of Fish Oil to Reduce ALT Levels in Adolescents

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Natural Modulators of Immune Function and Mood

Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer

Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies

A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid

Unsaturated Fatty Acids Enriched-diet to Improve Cardiorespiratory Fitness, Metabolic Flexibility and Glucose Tolerance in Obese Patients

Does Fish Oil Prevent Depression in Pregnancy and Postpartum?

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature

Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

Omega-3D: Omega-3 for Diet-Driven Health Disparities

A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Omega-3 Supplementation for Smell Dysfunction

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Efficacy of Fish Oil in Lupus Patients

Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)

Effect of Omega-3 Fatty Acid on Cortical Function in ADHD

Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing

Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study

Effect of High Omega-3 Fish Intake on Lipid Peroxidation